Data / Form D filings / Lumos Pharma, Inc.
Lumos Pharma, Inc.: Form D filings
Lumos Pharma, Inc., a pharmaceuticals company in Austin, TX, filed 3 Form D notices with the SEC between 2014 and 2016. The latest, on April 18, 2016, reports $34 million sold of a $34 million offering to 6 investors.
Find out what Lumos Pharma, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4200 Marathon Blvd., Suite 200, Austin, TX, 78756
- Phone
- (512) 215-2630
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2014
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1596584
The full lists. Form D filings in Texas: 4,800 rows, $128, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 18, 2016 | New notice | $33,999,991 | $33,999,991 | $0 | 6 | Apr 4, 2016 | sec.gov |
| May 1, 2015 | Amendment | $13,000,000 | $13,000,000 | $0 | 5 | Jan 24, 2014 | sec.gov |
| Feb 6, 2014 | New notice | $7,500,000 | $6,500,000 | $1,000,000 | 3 | Jan 24, 2014 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Michele Gilbert Park | Director | |
| G. Gilbert Cloyd | Director | |
| Kevin S. Lelande | Director | |
| Robert S. Heft | Director | |
| Cameron Gilbert Wheeler | Director | |
| Richard John Hawkins | Executive Officer, Director | |
| Edward Gilbert Mathers | Director | |
| Jon S. Saxe | Director | |
| Tracy Gilbert Saxton | Director |
Other pharmaceuticals companies in Texas that filed recently
- LUCIER PHARMACEUTICALS INC offering · Oct 13, 2026
- FibroBiologics, Inc. $1.2 million · Oct 13, 2026
- Eos SENOLYTIX, Inc. $750,000 · Aug 27, 2026
Every Form D from the week of Apr 18, 2016 · All recent filings in Texas · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Lumos Pharma, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.